Healthequity Inc
NASDAQ:HQY
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
US |
Healthequity Inc
NASDAQ:HQY
|
6.9B USD | 3.4 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
476.5B USD | 5.2 | ||
US |
Elevance Health Inc
NYSE:ELV
|
126.5B USD | 3.1 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 3.2 | ||
US |
Humana Inc
NYSE:HUM
|
42.4B USD | 2.6 | ||
US |
Centene Corp
NYSE:CNC
|
41.5B USD | 1.5 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20.1B USD | 4.5 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
31.9B BRL | 0.7 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 4.6 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
2.6B USD | 4.6 | ||
US |
Magellan Health Inc
NASDAQ:MGLN
|
2.5B USD | 1.3 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.